| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 144.747 | 843.973 | 1.284.771 |
| Total Income - EUR | - | - | - | - | - | - | - | 144.767 | 844.623 | 1.363.062 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 127.348 | 689.999 | 1.200.042 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 17.418 | 154.625 | 163.020 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 13.076 | 130.045 | 136.774 |
| Employees | - | - | - | - | - | - | - | 0 | 0 | 0 |
Check the financial reports for the company - Biomarket Ajos Gold S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 79.083 | 78.563 | 499.452 |
| Current Assets | - | - | - | - | - | - | - | 278.395 | 531.714 | 446.849 |
| Inventories | - | - | - | - | - | - | - | 99.153 | 389.945 | 19.234 |
| Receivables | - | - | - | - | - | - | - | 149.720 | 131.353 | 303.246 |
| Cash | - | - | - | - | - | - | - | 29.522 | 10.415 | 124.369 |
| Shareholders Funds | - | - | - | - | - | - | - | 13.116 | 143.121 | 279.095 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 344.362 | 467.155 | 677.258 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4631 - 4631" | |||||||||
| CAEN Financial Year |
4631
|
|||||||||
Comments - Biomarket Ajos Gold S.r.l.